person · Reporting owner
Jeffrey John Ronald Jr.
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ARGAN INCAGX · Entity 3828 | Director | July 31, 2026 | August 04, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ARGAN INC
Report date July 31, 2026 · Filed August 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,533 |
Reported balance
After 2026-07-31 transaction · row 1
1 source rowRow 1 · 2026-07-31 · Sale · Disposed 5,716 · Balance 2,533 F1: On July 31, 2026, the Reporting Person sold 5,716 shares of the Issuer's common stock on the open market at an average price of $579.64 per share. |
| Common StockSEC Table I · non-derivative | IndirectJohn R. Jeffrey, IRA | 8,000 |
Reported balance
Holding disclosure · report date 2026-07-31 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 8,000 |
Filing footnotes · ownership attribution and instrument terms
F1: On July 31, 2026, the Reporting Person sold 5,716 shares of the Issuer's common stock on the open market at an average price of $579.64 per share.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 31, 2026 Filed Aug 4, 2026 20:30 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 5,716 | $579.64 | $3,313,222.24 |
DisclosureSEC source: 0001709914-26-000028 · form4-08042026_040816.xml · nonDerivative · entry 1 Jeffrey John Ronald Jr. · CIK 0001709914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,533 F1 · shares: On July 31, 2026, the Reporting Person sold 5,716 shares of the Issuer's common stock on the open market at an average price of $579.64 per share. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 20:30 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionOption to Purchase Common Stock · Derivative | 1,000 | $43.70 Strike: $43.70 | $43,700.00 |
DisclosureSEC source: 0001709914-26-000024 · form4-07022026_040703.xml · derivative · entry 5 Jeffrey John Ronald Jr. · CIK 0001709914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500 Underlying: Common Stock · 1,000 shares Expires 2033-12-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On June 30, 2026, the Reporting Person exercised a portion of his stock option awarded on December 14, 2023 to purchase 1,000 shares of the Issuer's common stock at a price of $43.70 per share using the net settle method. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 20:30 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionOption to Purchase Common Stock · Derivative | 5,000 | $35.72 Strike: $35.72 | $178,600.00 |
DisclosureSEC source: 0001709914-26-000024 · form4-07022026_040703.xml · derivative · entry 4 Jeffrey John Ronald Jr. · CIK 0001709914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 5,000 shares Expires 2032-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On June 30, 2026, the Reporting Person exercised his stock option awarded on December 16, 2022 to purchase 5,000 shares of the Issuer's common stock at a price of $35.72 per share using the net settle method. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 20:30 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 944 | $43.70 | $41,252.80 |
DisclosureSEC source: 0001709914-26-000024 · form4-07022026_040703.xml · nonDerivative · entry 2 Jeffrey John Ronald Jr. · CIK 0001709914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,249 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On June 30, 2026, the Reporting Person exercised a portion of his stock option awarded on December 14, 2023 to purchase 1,000 shares of the Issuer's common stock at a price of $43.70 per share using the net settle method. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 20:30 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 4,772 | $35.72 | $170,455.84 |
DisclosureSEC source: 0001709914-26-000024 · form4-07022026_040703.xml · nonDerivative · entry 1 Jeffrey John Ronald Jr. · CIK 0001709914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,305 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On June 30, 2026, the Reporting Person exercised his stock option awarded on December 16, 2022 to purchase 5,000 shares of the Issuer's common stock at a price of $35.72 per share using the net settle method. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 20:30 UTC | ARGAN INC AGX · Entity 3828 | GrantTime-Based Restricted Stock Units · Derivative | 189 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001709914-26-000022 · form4-06122026_040607.xml · derivative · entry 4 Jeffrey John Ronald Jr. · CIK 0001709914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,023 Underlying: Common Stock · 189 shares Expires not disclosed F2 · derivative.exercise_date: On June 10, 2026 the Reporting Person was granted TRSUs covering 189 shares of the Issuer's common stock. The TRSUs will vest fully on June 10, 2027 or on the date of the 2027 Annual Meeting of Stockholders, whichever comes first. F2 · derivative.expiration_date: On June 10, 2026 the Reporting Person was granted TRSUs covering 189 shares of the Issuer's common stock. The TRSUs will vest fully on June 10, 2027 or on the date of the 2027 Annual Meeting of Stockholders, whichever comes first. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 20:30 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionTime-Based Restricted Stock Units · Derivative | 530 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001709914-26-000022 · form4-06122026_040607.xml · derivative · entry 3 Jeffrey John Ronald Jr. · CIK 0001709914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 834 Underlying: Common Stock · 530 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Pursuant to the one-year vesting schedule of the Time-Based Restricted Stock Units ("TRSUs") awarded to the Reporting Person on June 17, 2025, 530 shares of the Issuer's common stock became issuable to the Reporting Person on June 10, 2026 and is adjusted for dividends. F1 · derivative.expiration_date: Pursuant to the one-year vesting schedule of the Time-Based Restricted Stock Units ("TRSUs") awarded to the Reporting Person on June 17, 2025, 530 shares of the Issuer's common stock became issuable to the Reporting Person on June 10, 2026 and is adjusted for dividends. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 20:30 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 533 | $0.00 | $0.00 |
DisclosureSEC source: 0001709914-26-000022 · form4-06122026_040607.xml · nonDerivative · entry 1 Jeffrey John Ronald Jr. · CIK 0001709914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,533 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Pursuant to the one-year vesting schedule of the Time-Based Restricted Stock Units ("TRSUs") awarded to the Reporting Person on June 17, 2025, 530 shares of the Issuer's common stock became issuable to the Reporting Person on June 10, 2026 and is adjusted for dividends. Read SEC document |
| April 27, 2026 Filed Apr 29, 2026 21:00 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 2,698 | $664.84 | $1,793,738.32 |
DisclosureSEC source: 0001709914-26-000020 · form4-04292026_050401.xml · nonDerivative · entry 1 Jeffrey John Ronald Jr. · CIK 0001709914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,000 F1 · shares: On April 27, 2026, the Reporting Person sold 2,698 shares of the Issuer's common stock on the open market at an average price of $664.84 per share. Read SEC document |
| April 21, 2026 Filed Apr 22, 2026 21:00 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionOption to Purchase Common Stock · Derivative | 5,000 | $37.13 Strike: $37.13 | $185,650.00 |
DisclosureSEC source: 0001709914-26-000016 · form4-04222026_050401.xml · derivative · entry 4 Jeffrey John Ronald Jr. · CIK 0001709914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,500 Underlying: Common Stock · 5,000 shares Expires 2031-12-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On April 21, 2026, the Reporting Person exercised his stock option awarded on December 14, 2021 to purchase 5,000 shares of the Issuer's common stock at a price of $37.13 per share, using the net settle method. Read SEC document |
| April 21, 2026 Filed Apr 22, 2026 21:00 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 4,698 | $37.13 | $174,436.74 |
DisclosureSEC source: 0001709914-26-000016 · form4-04222026_050401.xml · nonDerivative · entry 2 Jeffrey John Ronald Jr. · CIK 0001709914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,698 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On April 21, 2026, the Reporting Person exercised his stock option awarded on December 14, 2021 to purchase 5,000 shares of the Issuer's common stock at a price of $37.13 per share, using the net settle method. Read SEC document |
| April 21, 2026 Filed Apr 22, 2026 21:00 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 3,636 | $615.40 | $2,237,594.40 |
DisclosureSEC source: 0001709914-26-000016 · form4-04222026_050401.xml · nonDerivative · entry 1 Jeffrey John Ronald Jr. · CIK 0001709914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · shares: On April 21, 2026, the Reporting Person sold 3,636 shares of the Issuer's common stock on the open market at an average price of $615.40 per share. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 21:00 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 4,556 | $539.85 | $2,459,556.60 |
DisclosureSEC source: 0001709914-26-000012 · form4-04022026_050401.xml · nonDerivative · entry 1 Jeffrey John Ronald Jr. · CIK 0001709914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,636 F1 · shares: On March 31, 2026, the Reporting Person sold 4,556 shares of the Issuer's common stock on the open market at an average price of $539.85 per share. Read SEC document |
| January 27, 2026 Filed Jan 29, 2026 22:00 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 5,000 | $360.78 | $1,803,900.00 |
DisclosureSEC source: 0001709914-26-000008 · form4-01292026_050101.xml · nonDerivative · entry 1 Jeffrey John Ronald Jr. · CIK 0001709914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,192 F1 · shares: On January 27, 2026, the Reporting Person sold 5,000 shares of the Issuer's common stock on the open market at an average price of $360.78 per share. Read SEC document |
| January 20, 2026 Filed Jan 21, 2026 22:00 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 2,700 | $380.60 | $1,027,620.00 |
DisclosureSEC source: 0001709914-26-000004 · form4-01212026_050104.xml · nonDerivative · entry 2 Jeffrey John Ronald Jr. · CIK 0001709914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,192 F2 · shares: On January 20, 2026, the Reporting Person sold 2,700 shares of the Issuer's common stock on the open market at an average price of $380.60 per share. Read SEC document |
| January 16, 2026 Filed Jan 21, 2026 22:00 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionOption to Purchase Common Stock · Derivative | 10,000 | $45.75 Strike: $45.75 | $457,500.00 |
DisclosureSEC source: 0001709914-26-000004 · form4-01212026_050104.xml · derivative · entry 4 Jeffrey John Ronald Jr. · CIK 0001709914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,500 Underlying: Common Stock · 10,000 shares Expires 2030-12-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On January 16, 2026, the Reporting Person exercised his stock option awarded on December 14, 2020 to purchase 10,000 shares of the Issuer's common stock at a price of $45.75 per share, using the net settle method. Read SEC document |
| January 16, 2026 Filed Jan 21, 2026 22:00 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 8,636 | $45.75 | $395,097.00 |
DisclosureSEC source: 0001709914-26-000004 · form4-01212026_050104.xml · nonDerivative · entry 1 Jeffrey John Ronald Jr. · CIK 0001709914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,892 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On January 16, 2026, the Reporting Person exercised his stock option awarded on December 14, 2020 to purchase 10,000 shares of the Issuer's common stock at a price of $45.75 per share, using the net settle method. Read SEC document |
| December 16, 2025 Filed Dec 17, 2025 23:27 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionTime-Based Restricted Stock Units · Derivative | 1,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001709914-25-000009 · form4-12172025_111229.xml · derivative · entry 5 Jeffrey John Ronald Jr. · CIK 0001709914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,364 Underlying: Common Stock · 1,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on December 16, 2022, 1,750 shares of common stock became issuable to the Reporting Person on December 16, 2025 and is adjusted for dividends. F2 · derivative.expiration_date: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on December 16, 2022, 1,750 shares of common stock became issuable to the Reporting Person on December 16, 2025 and is adjusted for dividends. Read SEC document |
| December 16, 2025 Filed Dec 17, 2025 23:27 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 1,844 | $0.00 | $0.00 |
DisclosureSEC source: 0001709914-25-000009 · form4-12172025_111229.xml · nonDerivative · entry 2 Jeffrey John Ronald Jr. · CIK 0001709914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,256 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on December 16, 2022, 1,750 shares of common stock became issuable to the Reporting Person on December 16, 2025 and is adjusted for dividends. Read SEC document |
| December 14, 2025 Filed Dec 17, 2025 23:27 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionTime-Based Restricted Stock Units · Derivative | 833 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001709914-25-000009 · form4-12172025_111229.xml · derivative · entry 4 Jeffrey John Ronald Jr. · CIK 0001709914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,114 Underlying: Common Stock · 833 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on December 14, 2023, 833 shares of common stock became issuable to the Reporting Person on December 14, 2025 and is adjusted for dividends. F1 · derivative.expiration_date: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on December 14, 2023, 833 shares of common stock became issuable to the Reporting Person on December 14, 2025 and is adjusted for dividends. Read SEC document |
| December 14, 2025 Filed Dec 17, 2025 23:27 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 856 | $0.00 | $0.00 |
DisclosureSEC source: 0001709914-25-000009 · form4-12172025_111229.xml · nonDerivative · entry 1 Jeffrey John Ronald Jr. · CIK 0001709914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,412 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on December 14, 2023, 833 shares of common stock became issuable to the Reporting Person on December 14, 2025 and is adjusted for dividends. Read SEC document |
| September 29, 2025 Filed Oct 1, 2025 20:15 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 4,698 | $268.60 | $1,261,882.80 |
DisclosureSEC source: 0001709914-25-000007 · form4-10012025_041010.xml · nonDerivative · entry 1 Jeffrey John Ronald Jr. · CIK 0001709914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,556 F1 · shares: On September 29, 2025, the Reporting Person sold 4,698 shares of the Issuer's common stock on the open market at an average price of $268.60 per share. Read SEC document |
| July 29, 2025 Filed Jul 31, 2025 20:15 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 2,621 | $235.63 | $617,586.23 |
DisclosureSEC source: 0001415889-25-020719 · form4-07312025_040701.xml · nonDerivative · entry 1 Jeffrey John Ronald Jr. · CIK 0001709914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,254 F1 · shares: On July 29, 2025, the Reporting Person sold 2,621 shares of the Issuer's common stock on the open market at an average price of $235.63 per share. Read SEC document |
| June 17, 2025 Filed Jun 20, 2025 20:15 UTC | ARGAN INC AGX · Entity 3828 | GrantTime-Based Restricted Stock Units · Derivative | 530 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-017831 · form4-06202025_040621.xml · derivative · entry 1 Jeffrey John Ronald Jr. · CIK 0001709914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,947 Underlying: Common Stock · 530 shares Expires not disclosed F1 · derivative.exercise_date: On June 17, 2025, the Reporting Person was granted Time-Based Restricted Stock Units ("TRSUs") covering 530 shares of the Issuer's common stock. The TRSUs will vest fully on April 17, 2026. F1 · derivative.expiration_date: On June 17, 2025, the Reporting Person was granted Time-Based Restricted Stock Units ("TRSUs") covering 530 shares of the Issuer's common stock. The TRSUs will vest fully on April 17, 2026. Read SEC document |
| June 10, 2025 Filed Jun 11, 2025 20:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionTime-Based Restricted Stock Units · Derivative | 388 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-016656 · form4-06112025_040603.xml · derivative · entry 4 Jeffrey John Ronald Jr. · CIK 0001709914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,417 Underlying: Common Stock · 388 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Pursuant to the six-month vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on December 12, 2024, 388 shares of Common Stock became issuable to the Reporting Person on June 10, 2025 and is adjusted for dividends. F2 · derivative.expiration_date: Pursuant to the six-month vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on December 12, 2024, 388 shares of Common Stock became issuable to the Reporting Person on June 10, 2025 and is adjusted for dividends. Read SEC document |
| June 10, 2025 Filed Jun 11, 2025 20:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 390 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-016656 · form4-06112025_040603.xml · nonDerivative · entry 2 Jeffrey John Ronald Jr. · CIK 0001709914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,875 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Pursuant to the six-month vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on December 12, 2024, 388 shares of Common Stock became issuable to the Reporting Person on June 10, 2025 and is adjusted for dividends. Read SEC document |
| June 09, 2025 Filed Jun 11, 2025 20:15 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 5,500 | $217.79 | $1,197,845.00 |
DisclosureSEC source: 0001415889-25-016656 · form4-06112025_040603.xml · nonDerivative · entry 1 Jeffrey John Ronald Jr. · CIK 0001709914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,485 F1 · shares: On June 9, 2025, the Reporting Person sold 5,500 shares of the Issuer's common stock on the open market at an average price of $217.79 per share. Read SEC document |
| January 17, 2025 Filed Jan 22, 2025 21:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionOption to Purchase Common Stock · Derivative | 10,000 | $40.15 Strike: $40.15 | $401,500.00 |
DisclosureSEC source: 0001415889-25-001850 · form4-01222025_040101.xml · derivative · entry 3 Jeffrey John Ronald Jr. · CIK 0001709914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,500 Underlying: Common Stock · 10,000 shares Expires 2029-12-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On January 17, 2025, the Reporting Person exercised his stock option awarded on December 23, 2019 to purchase 10,000 shares of the Issuer's common stock at a price of $40.15 per share, using the net settle method. Read SEC document |
| January 17, 2025 Filed Jan 22, 2025 21:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 7,731 | $40.15 | $310,399.65 |
DisclosureSEC source: 0001415889-25-001850 · form4-01222025_040101.xml · nonDerivative · entry 1 Jeffrey John Ronald Jr. · CIK 0001709914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,985 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On January 17, 2025, the Reporting Person exercised his stock option awarded on December 23, 2019 to purchase 10,000 shares of the Issuer's common stock at a price of $40.15 per share, using the net settle method. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:15 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 5,000 | $138.99 | $694,950.00 |
DisclosureSEC source: 0001415889-25-000399 · form4-01032025_040101.xml · nonDerivative · entry 1 Jeffrey John Ronald Jr. · CIK 0001709914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,254 F1 · shares: On December 31, 2024, the Reporting Person sold 5,000 shares of the Issuer's common stock on the open market at an average price of $138.99 per share. Read SEC document |
| December 20, 2024 Filed Dec 23, 2024 21:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionOption to Purchase Common Stock · Derivative | 10,000 | $41.19 Strike: $41.19 | $411,900.00 |
DisclosureSEC source: 0001415889-24-030055 · form4-12232024_041201.xml · derivative · entry 3 Jeffrey John Ronald Jr. · CIK 0001709914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,500 Underlying: Common Stock · 10,000 shares Expires 2028-12-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On December 20, 2024, the Reporting Person exercised his stock option awarded to him on December 12, 2018 to purchase 10,000 shares of the Issuer's common stock at a price of $41.19 per share, using the net settle method. Read SEC document |
| December 20, 2024 Filed Dec 23, 2024 21:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 6,964 | $41.19 | $286,847.16 |
DisclosureSEC source: 0001415889-24-030055 · form4-12232024_041201.xml · nonDerivative · entry 1 Jeffrey John Ronald Jr. · CIK 0001709914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,254 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On December 20, 2024, the Reporting Person exercised his stock option awarded to him on December 12, 2018 to purchase 10,000 shares of the Issuer's common stock at a price of $41.19 per share, using the net settle method. Read SEC document |
| December 14, 2024 Filed Dec 16, 2024 21:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionTime-Based Restricted Stock Units · Derivative | 833 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-029469 · form4-12162024_041207.xml · derivative · entry 6 Jeffrey John Ronald Jr. · CIK 0001709914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,805 Underlying: Common Stock · 833 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Pursuant to the three-year vesting schedule of the TRSU awarded to the Reporting Person on December 14, 2023, 833 shares of Common Stock became issuable to the Reporting Person on December 14, 2024 and is adjusted for dividends. F2 · derivative.expiration_date: Pursuant to the three-year vesting schedule of the TRSU awarded to the Reporting Person on December 14, 2023, 833 shares of Common Stock became issuable to the Reporting Person on December 14, 2024 and is adjusted for dividends. Read SEC document |
| December 14, 2024 Filed Dec 16, 2024 21:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionTime-Based Restricted Stock Units · Derivative | 1,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-029469 · form4-12162024_041207.xml · derivative · entry 5 Jeffrey John Ronald Jr. · CIK 0001709914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,638 Underlying: Common Stock · 1,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on December 14, 2021, 1,750 shares of Common Stock became issuable to the Reporting Person on December 14, 2024 and is adjusted for dividends. F1 · derivative.expiration_date: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on December 14, 2021, 1,750 shares of Common Stock became issuable to the Reporting Person on December 14, 2024 and is adjusted for dividends. Read SEC document |
| December 14, 2024 Filed Dec 16, 2024 21:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 835 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-029469 · form4-12162024_041207.xml · nonDerivative · entry 2 Jeffrey John Ronald Jr. · CIK 0001709914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,290 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Pursuant to the three-year vesting schedule of the TRSU awarded to the Reporting Person on December 14, 2023, 833 shares of Common Stock became issuable to the Reporting Person on December 14, 2024 and is adjusted for dividends. Read SEC document |
| December 14, 2024 Filed Dec 16, 2024 21:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 1,757 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-029469 · form4-12162024_041207.xml · nonDerivative · entry 1 Jeffrey John Ronald Jr. · CIK 0001709914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,455 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on December 14, 2021, 1,750 shares of Common Stock became issuable to the Reporting Person on December 14, 2024 and is adjusted for dividends. Read SEC document |
| December 12, 2024 Filed Dec 16, 2024 21:15 UTC | ARGAN INC AGX · Entity 3828 | GrantTime-Based Restricted Stock Units · Derivative | 388 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-029469 · form4-12162024_041207.xml · derivative · entry 4 Jeffrey John Ronald Jr. · CIK 0001709914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,388 Underlying: Common Stock · 388 shares Expires not disclosed F3 · derivative.exercise_date: On December 12, 2024, the Reporting Person was granted TRSUs covering 388 shares of the Issuer's common stock. The TRSUs will vest fully on June 10, 2025. F3 · derivative.expiration_date: On December 12, 2024, the Reporting Person was granted TRSUs covering 388 shares of the Issuer's common stock. The TRSUs will vest fully on June 10, 2025. Read SEC document |
| June 12, 2024 Filed Jun 13, 2024 20:05 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionOption to Purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $60.05 | $0.00 |
DisclosureSEC source: 0001415889-24-016647 · form4-06132024_040603.xml · derivative · entry 3 Jeffrey John Ronald Jr. · CIK 0001709914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,500 Underlying: Common Stock · 10,000 shares Expires 2027-06-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On June 12, 2024, the Reporting Person exercised his option awarded on June 22, 2017 to purchase 10,000 shares of the Issuer's common stock at a price of $60.05 per share, using the net settle approach. Read SEC document |
| June 12, 2024 Filed Jun 13, 2024 20:05 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 2,296 | $60.05 | $137,874.80 |
DisclosureSEC source: 0001415889-24-016647 · form4-06132024_040603.xml · nonDerivative · entry 1 Jeffrey John Ronald Jr. · CIK 0001709914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,698 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On June 12, 2024, the Reporting Person exercised his option awarded on June 22, 2017 to purchase 10,000 shares of the Issuer's common stock at a price of $60.05 per share, using the net settle approach. Read SEC document |
| April 25, 2024 Filed Apr 26, 2024 22:39 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionOption to Purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $46.35 | $0.00 |
DisclosureSEC source: 0001415889-24-011612 · form4-04262024_100449.xml · derivative · entry 3 Jeffrey John Ronald Jr. · CIK 0001709914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,500 Underlying: Common Stock · 10,000 shares Expires 2028-01-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On April 25, 2024, the Reporting Person exercised his option awarded on January 11, 2018 to purchase 10,000 shares of the Issuer's common stock at a price of $46.35 per share, using the nettle settle approach. Read SEC document |
| April 25, 2024 Filed Apr 26, 2024 22:39 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 2,402 | $46.35 | $111,332.70 |
DisclosureSEC source: 0001415889-24-011612 · form4-04262024_100449.xml · nonDerivative · entry 1 Jeffrey John Ronald Jr. · CIK 0001709914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,402 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On April 25, 2024, the Reporting Person exercised his option awarded on January 11, 2018 to purchase 10,000 shares of the Issuer's common stock at a price of $46.35 per share, using the nettle settle approach. Read SEC document |
| December 14, 2023 Filed Dec 18, 2023 22:13 UTC | ARGAN INC AGX · Entity 3828 | GrantTime-Based Restricted Stock Units · Derivative | 2,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-016614 · form4-12182023_101256.xml · derivative · entry 2 Jeffrey John Ronald Jr. · CIK 0001709914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 2,500 shares Expires 2026-12-14 F2 · shares: On December 14, 2023, the Reporting Person was granted Time-Based Restricted Stock Units ("TRSUs") covering 2,500 shares of common stock. The TRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 12/14/2024. Read SEC document |
| December 14, 2023 Filed Dec 18, 2023 22:13 UTC | ARGAN INC AGX · Entity 3828 | GrantOption to Purchase Common Stock · Derivative | 1,500 | $0.00 Strike: $43.70 | $0.00 |
DisclosureSEC source: 0001415889-23-016614 · form4-12182023_101256.xml · derivative · entry 1 Jeffrey John Ronald Jr. · CIK 0001709914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,500 Underlying: Common Stock · 1,500 shares Expires 2033-12-14 F1 · shares: On December 14, 2023, the Reporting Person received 10-year options to purchase 1,500 shares of the Issuer's common stock with an exercise price of $43.70 per share. The options will vest ratably over three years on each anniversary of the grant date starting from 12/14/2024. Read SEC document |
| December 16, 2022 Filed Dec 20, 2022 21:15 UTC | ARGAN INC AGX · Entity 3828 | GrantTime-Based Restricted Stock Units · Derivative | 1,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-012849 · form4-12202022_041225.xml · derivative · entry 2 Jeffrey John Ronald Jr. · CIK 0001709914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,500 Underlying: Common Stock · 1,750 shares Expires 2025-12-16 F4 · shares: On December 16, 2022, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 1,750 shares of common stock. The TBRSUs will vest in their entirety on the third anniversary of the grant date on 12/16/2025. F5 · balance_after: As of the date of this filing, the total number of TBRSUs beneficially owned by the Reporting Person includes (a) 1,750 shares of TBRSUs granted on December 14, 2021 and (b) 1,750 shares of TBRSUs granted on December 16, 2022. All are to vest in their entirety on the third anniversary of their respective grant date. Read SEC document |
| December 16, 2022 Filed Dec 20, 2022 21:15 UTC | ARGAN INC AGX · Entity 3828 | GrantOption to Purchase Common Stock · Derivative | 5,000 | $0.00 Strike: $35.72 | $0.00 |
DisclosureSEC source: 0001415889-22-012849 · form4-12202022_041225.xml · derivative · entry 1 Jeffrey John Ronald Jr. · CIK 0001709914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 5,000 shares Expires 2032-12-16 F1 · shares: On December 16, 2022, the Reporting Person received 10-year options to purchase 5,000 shares of the Issuer's Common Stock at an exercise price of $35.72 per share. The options will vest ratably over three years on each anniversary of the grant date beginning on 12/16/2023 F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 10,000 shares of common stock at a price of $60.05 per share with initial Date Exercisable of 06/22/2018 and Expiration Date of 06/22/2027; (b) 10,000 shares of common stock at a price of $46 35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; (c) 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable of 12/12/2019 and Expiration Date of 12/12/2028; (d) 10,000 shares of common stock at a price of $40.15 per share with initial Date Exercisable of 12/23/2020 and Expiration Date of 12/23/2029; (e) 10,000 shares of common stock at a price of $45.75 per share with initial Date Exercisable 12/14/2021 and Expiration Date of 12/14/2030; (f) 5,000 shares of common stock at a price of $37.13 per share with initial Date Exercisable of 12/14/2022 and Expiration Date of 12/14/2031; and F3 · balance_after: (g) 5,000 shares of common stock at a price of $35.72 per share with initial Date Exercisable of 12/16/2023 and Expiration Date of 12/16/2032. All stock options are subject to the aforementioned three-year ratable vesting schedule except those awarded prior to January 2018 which vested fully on the first anniversary of the date of award. Read SEC document |
| May 06, 2022 Filed May 9, 2022 20:15 UTC | ARGAN INC AGX · Entity 3828 | PurchaseCommon Stock | 1,000 | $36.70 | $36,700.00 |
DisclosureSEC source: 0001415889-22-004769 · form4-05092022_040501.xml · nonDerivative · entry 1 Jeffrey John Ronald Jr. · CIK 0001709914 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · John R. Jeffrey, IRA Disclosed balance after: 8,000 F1 · shares: On May 6, 2022, the Reporting Person purchased 1,000 shares of the Issuer's Common Stock on the open market at a price of $36.70 per share. Read SEC document |
| April 22, 2022 Filed Apr 22, 2022 20:29 UTC | ARGAN INC AGX · Entity 3828 | PurchaseCommon Stock | 1,000 | $36.97 | $36,970.00 |
DisclosureSEC source: 0001415889-22-004228 · form4-04222022_010456.xml · nonDerivative · entry 1 Jeffrey John Ronald Jr. · CIK 0001709914 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · John R. Jeffrey, IRA Disclosed balance after: 7,000 F1 · shares: On April 22, 2022, the Reporting Person purchased 1,000 shares of the Issuer's Common Stock on the open market at a price of $36.97 per share. Read SEC document |
| December 14, 2021 Filed Dec 16, 2021 21:15 UTC | ARGAN INC AGX · Entity 3828 | GrantTime-Based Restricted Stock Units · Derivative | 1,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-006026 · form4-12162021_041211.xml · derivative · entry 3 Jeffrey John Ronald Jr. · CIK 0001709914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,750 Underlying: Common Stock · 1,750 shares Expires 2024-12-14 F4 · shares: On December 14, 2021, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 1,750 shares of common stock. The TBRSUs will vest in their entirety on the third anniversary of the grant date on 12/14/2024. Read SEC document |
| December 14, 2021 Filed Dec 16, 2021 21:15 UTC | ARGAN INC AGX · Entity 3828 | GrantOption to Purchase Common Stock · Derivative | 5,000 | $0.00 Strike: $37.13 | $0.00 |
DisclosureSEC source: 0001415889-21-006026 · form4-12162021_041211.xml · derivative · entry 2 Jeffrey John Ronald Jr. · CIK 0001709914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 5,000 shares Expires 2031-12-14 F1 · shares: On December 14, 2021, the Reporting Person received 10-year options to purchase 5,000 shares of the Issuer's Common Stock at an exercise price of $37.13 per share. The options will vest ratably over three years on each anniversary of the grant date beginning on 12/14/2022. F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 10,000 shares of common stock at a price of $60.05 per share with initial Date Exercisable of 06/22/2018 and Expiration Date of 06/22/2027; (b) 10,000 shares of common stock at a price of $46 35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; (c) 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable of 12/12/2019 and Expiration Date of 12/12/2028; (d) 10,000 shares of common stock at a price of $40.15 per share with initial Date Exercisable of 12/23/2020 and Expiration Date of 12/23/2029; F3 · balance_after: (e) 10,000 shares of common stock at a price of $45.75 per share with initial Date Exercisable 12/14/2021 and Expiration Date of 12/14/2030; and (f) 5,000 shares of common stock at a price of $37.13 per share with initial Date Exercisable of 12/14/2022 and Expiration Date of 12/14/2031. All stock options are subject to the aforementioned three-year ratable vesting schedule except those awarded prior to January 2018 which vested fully on the first anniversary of the date of award. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 21:17 UTC | ARGAN INC AGX · Entity 3828 | GrantStock Option to Purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $45.75 | $0.00 |
DisclosureSEC source: 0001104659-20-136295 · tm2038593-3_4seq1.xml · derivative · entry 2 Jeffrey John Ronald Jr. · CIK 0001709914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 10,000 shares Expires 2030-12-14 F1 · shares: On December 14, 2020, the Reporting Person received 10-year options to purchase 10,000 shares of the Issuer's Common stock at an exercise price of $45.75 per share. The options will vest ratably over three years on each anniversary of the grant date beginning on 12/14/2021. F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 10,000 shares of common stock at a price of $60.05 per share with initial Date Exercisable of 06/22/2018 and Expiration Date of 06/22/2027; (b) 10,000 shares of common stock at a price of $46 35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; (c) 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable of 12/12/2019 and Expiration Date of 12/12/2028; (d) 10,000 shares of common stock at a price of $40.15 per share with initial Date Exercisable of 12/23/2020 and Expiration Date of 12/23/2029; and F3 · balance_after: (e) 10,00 shares of common stock at a price of $45.75 per share with initial Date Exercisable 12/14/2021 and Expiration Date of 12/14/2030, all of which are subject to the aforementioned three-year ratably vesting schedule. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.